ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB)

Q2 2019 13F Holders as of 6/30/2019

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 52.3M
Number of holders: 89
Total 13F shares, excl. options: 32.5M
Shares change: +865K
Total reported value, excl. options: $109M
Value change: +$3M
Number of buys: 45
Number of sells: -28
Price: $3.37

Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q2 2019

93 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q2 2019.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.5M shares of 52.3M outstanding shares and own 62.09% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.17M shares), WELLINGTON MANAGEMENT GROUP LLP (3.86M shares), BlackRock Inc. (3.69M shares), Evermore Global Advisors, LLC (3.59M shares), RENAISSANCE TECHNOLOGIES LLC (3.25M shares), VANGUARD GROUP INC (2.26M shares), DIMENSIONAL FUND ADVISORS LP (2.14M shares), Roumell Asset Management, LLC (1.24M shares), STATE STREET CORP (772K shares), and NORTHERN TRUST CORP (562K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.